Targeting the membrane-anchored serine protease testisin with a novel engineered anthrax toxin prodrug to kill tumor cells and reduce tumor burden

Erik W. Martin(National Institute on Aging), Toni Antalis(QIMR Berghofer Medical Research Institute)
Oncotarget
September 15, 2015
Cited by 16


Related Papers